- Report
- January 2026
- 181 Pages
Global
From €3182EUR$3,545USD£2,775GBP
€3535EUR$3,939USD£3,084GBP
- Report
- February 2026
- 250 Pages
Global
From €4030EUR$4,490USD£3,515GBP
- Report
- January 2026
- 281 Pages
Global
From €2244EUR$2,500USD£1,957GBP
- Report
- October 2025
- 160 Pages
Global
From €3013EUR$3,358USD£2,629GBP
€3545EUR$3,950USD£3,092GBP
- Report
- February 2026
- 160 Pages
Global
From €2980EUR$3,320USD£2,599GBP
€3724EUR$4,150USD£3,249GBP
- Report
- July 2025
- 150 Pages
Global
From €5340EUR$5,950USD£4,658GBP
- Report
- January 2026
- 181 Pages
Global
From €3182EUR$3,545USD£2,775GBP
€3535EUR$3,939USD£3,084GBP
- Report
- January 2026
- 199 Pages
Global
From €3182EUR$3,545USD£2,775GBP
€3535EUR$3,939USD£3,084GBP
- Report
- November 2025
- 188 Pages
Global
From €3182EUR$3,545USD£2,775GBP
€3535EUR$3,939USD£3,084GBP
- Report
- August 2025
- 182 Pages
Global
From €3182EUR$3,545USD£2,775GBP
€3535EUR$3,939USD£3,084GBP
- Report
- August 2025
- 186 Pages
Global
From €3182EUR$3,545USD£2,775GBP
€3535EUR$3,939USD£3,084GBP
- Report
- August 2025
- 196 Pages
Global
From €3182EUR$3,545USD£2,775GBP
€3535EUR$3,939USD£3,084GBP
- Report
- August 2025
- 182 Pages
Global
From €3182EUR$3,545USD£2,775GBP
€3535EUR$3,939USD£3,084GBP
- Report
- August 2025
- 199 Pages
Global
From €3182EUR$3,545USD£2,775GBP
€3535EUR$3,939USD£3,084GBP
- Report
- August 2025
- 186 Pages
Global
From €3182EUR$3,545USD£2,775GBP
€3535EUR$3,939USD£3,084GBP
- Report
- April 2026
- 270 Pages
Global
From €5250EUR$5,850USD£4,580GBP
- Report
- April 2026
- 340 Pages
Global
From €5250EUR$5,850USD£4,580GBP
- Report
- January 2026
- 180 Pages
Global
From €4039EUR$4,500USD£3,523GBP
- Report
- January 2026
- 130 Pages
Global
From €4263EUR$4,750USD£3,719GBP
- Report
- May 2025
- 150 Pages
Global
From €4353EUR$4,850USD£3,797GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more